Mobile Menu

Search Results

Search results for: NHS

FoG 2020 Presentation Mike Hubank NHS England Genomics Lab Hub: Using CRISPR-CAS9 for rapid gene fusion detection

Mike Hubank, Scientific Director at NHS England Genomics Lab Hub spoke at the Festival of Genomics 2020.

Direct-to-consumer testing: The secrets in your genome

A quick Google search for genetic testing will point you towards all kinds of at-home kits, promising to reveal the […]

Sickle Cell Disease: A 2024 Update

Over the last few months, including just in the last week, there have been multiple reports on new treatments for […]

Genomics Week in Brief: Week Ending 31st May

Welcome back to Week in Brief, where we’ve summarised the biggest news in the genomics world! The NHS has made […]

Genomics Week in Brief: Week Ending 26th April

It’s that time of the week again – check out the latest stories from the genomics world and beyond in […]

Molecular Analysis for Precision Oncology ONLINE

Oncological care increasingly relies on molecular tumor characterization techniques to enhance patient outcomes. However, the clinical utility of some of these methods remains uncertain, potentially affecting their integration into healthcare systems. With all these new advancements, it can be challenging to stay up to date on the clinical applications and future prospects of these precision oncology techniques.

Join us for our latest webinar series, Molecular Analysis for Precision Oncology ONLINE, where we’ll hear insights from nine leading experts in the cancer genomics field, covering cutting-edge tumour characterisation techniques and their clinical applications.

The State Of: Newborn Sequencing

Newborn sequencing has been a hot topic in the news in recent years. From Guinness World Records to large-scale screening […]

Clinical Trials – What is holding liquid biopsy back?

This feature is written using content from our recently published Liquid Biopsy report, which you can read in full by […]

Liquid Biopsy Report – A New Era in Disease Detection and Surveillance

Liquid biopsy is poised to redefine the way we approach diagnostics and personalized medicine in the treatment of complex diseases. […]

ctDNA Tests for Early Cancer Detection – Are We There Yet?

It is well established that detecting and diagnosing cancer earlier significantly improves patient outcomes. Therefore, the identification of cancer biomarkers […]